V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280006188 | 280003819 | 1.71 | 73.8 | Palliative (P) | 2017-07-23 | 2017-08-17 | Carboplatin + Liposomal Doxorubicin | N | N | 280030432 | AZACITIDINE |
| 280006189 | 280003819 | 1.75 | 60.8 | Palliative (P) | 2017-03-16 | 2017-03-16 | Gemcitabine 1000mg/m2 D1 8 15 | 02 | N | 280030432 | AXITINIB |
| 280006190 | 280003820 | 1.65 | 68.2 | Adjuvant (A) | 2015-05-07 | 2015-05-09 | CISPLATIN + FLUOROURACIL + RT | 02 | N | 280030436 | GEMCARBO |
| 280006191 | 280003820 | 1.75 | 58.6 | Palliative (P) | 2018-01-04 | 2018-01-14 | VINORELBINE | 02 | N | 280030436 | PACLITAXEL |
| 280006192 | 280003820 | null | 12.5 | null | 2014-07-18 | 2014-08-01 | Bevacizumab + Capecitabine | N | N | 280030436 | FLUOROURACIL + MITOMYCIN + RT |
| 280006193 | 280003821 | 1.58 | 0 | Palliative (P) | 2018-09-02 | 2018-09-16 | CARBOPLATIN + CETUXIMAB | 2 | N | 280030444 | AC |
| 280006194 | 280003821 | 1.88 | 84.7 | Palliative (P) | 2016-10-17 | 2016-10-19 | Capecitabine | 02 | N | 280030444 | CARBOPLATIN + CETUXIMAB + FU |
| 280006195 | 280003822 | 1.8 | null | Palliative (P) | 2016-12-31 | 2017-01-07 | AFLIBERCEPT + FU + IRINOTECAN | N | null | 280030448 | PACLITAXEL |
| 280006196 | 280003822 | 1.7 | null | Palliative (P) | null | 2016-11-10 | Liposomal Doxorubicin 50mg/m2 | null | null | 280030448 | DOCETAXEL + GEMCITABINE |
| 280006197 | 280003822 | 1.62 | 73.2 | Palliative (P) | 2015-02-27 | 2015-03-05 | Mitomycin Intravesical | Y | Y | 280030448 | CISPLATIN + DOCETAXEL |
| 280006198 | 280011111 | 1.71 | null | Palliative (P) | 2018-03-30 | 2018-04-13 | Carbo F | Y | Y | 280030457 | DOXORUBICIN + OLARATUMAB |
| 280006199 | 280003823 | 1.51 | 63.3 | Palliative (P) | 2016-02-01 | 2016-02-14 | IPM | 02 | N | 280030458 | CETUXIMAB + CISPLATIN + FU |
| 280006200 | 280003823 | null | 67.1 | Not known (9) | 2016-11-12 | 2016-11-16 | Doxorubicin + Olaratumab | N | N | 280030458 | BENDAMUSTINE + RITUXIMAB |
| 280006201 | 280010102 | 1.7 | 57.3 | Palliative (P) | 2015-11-19 | 2015-11-21 | Doxorubicin + Olaratumab | 02 | N | 280030464 | CISPLATIN + DOXORUBICIN |
| 280006202 | 280003824 | 1.66 | 56.2 | Palliative (P) | 2016-02-22 | 2016-02-22 | Carboplatin+Fluorouracil 4 or 5 day | Y | Y | 280030465 | CISPLATIN + PEMETREXED |
| 280006203 | 280003824 | 1.6 | 82 | Palliative (P) | 2017-01-17 | 2017-01-17 | CARBOPLATIN + VINORELBINE | 02 | N | 280030465 | DOXORUBICIN + OLARATUMAB |
| 280006204 | 280003824 | 1.63 | 114 | Disease modification (D) | 2015-11-23 | 2015-12-12 | CEDIRANIB | 02 | N | 280030465 | CTD |
| 280006205 | 280003824 | null | null | Palliative (P) | 2017-02-15 | 2017-03-12 | STS Rhabdomyosarcoma RMS 2005 IVA | N | N | 280030465 | TRASTUZUMAB |
| 280006206 | 280003824 | 1.52 | 50.1 | Palliative (P) | null | 2017-07-25 | Doxorubicin + Olaratumab | N | N | 280030465 | CARBOPLATIN + PEMETREXED |
| 280006207 | 280003825 | null | 66.85 | Curative (C) | 2015-03-21 | 2015-04-10 | Capecitabine + Streptozocin | 2 | N | 280030481 | VIDE |
| 280006208 | 280003826 | null | null | Palliative (P) | 2013-06-10 | 2013-06-18 | Capecitabine + Oxaliplatin 14day | null | N | 280030483 | IVA |
| 280006209 | 280003827 | 1.76 | 71.6 | Curative (C) | 2014-08-09 | 2014-08-16 | ECX | N | N | 280030485 | CISPLATIN + FLUOROURACIL + RT |
| 280006210 | 280003827 | 1.67 | 77.2 | Neo-adjuvant (N) | 2014-08-04 | 2014-08-31 | FLUOROURACIL + MITOMYCIN + RT | N | N | 280030485 | CARBO + FLUOROURACIL |
| 280006211 | 280003827 | null | 82 | Not known (9) | 2017-02-15 | 2017-03-06 | Cisplatin + Doxorubicin | 2 | N | 280030485 | DASATINIB |
| 280006212 | 280003828 | 1.68 | 68.9 | Palliative (P) | 2018-06-04 | 2018-07-08 | Capecitabine | 02 | Y | 280030490 | CISPLATIN + VINORELBINE |
| 280006213 | 280003828 | 1.66 | 60 | Neo-adjuvant (N) | 2013-11-11 | 2013-11-19 | Carboplatin+Fluorouracil 4 or 5 day | N | N | 280030490 | VIDE |
| 280006214 | 280010105 | 1.72 | 95 | Adjuvant (A) | 2016-04-10 | 2016-04-10 | CAPECITABINE + CARBOPLATIN | 2 | N | 280030495 | CAPECITABINE + RT |
| 280006215 | 280003829 | null | null | Palliative (P) | 2014-06-28 | 2014-07-08 | Carboplatin+Fluorouracil 4 or 5 day | Y | N | 280030499 | DOXORUBICIN + OLARATUMAB |
| 280006216 | 280003829 | 1.62 | 101.4 | Curative (C) | 2017-11-02 | 2017-06-03 | GemCarbo Days 1+8 | null | N | 280030499 | CHOP R |
| 280006217 | 280003830 | 1.76 | 122.8 | Palliative (P) | 2016-08-31 | 2016-09-14 | Carbo F | N | N | 280030501 | VIDE |
| 280006218 | 280003831 | 1.62 | 100 | Neo-adjuvant (N) | 2017-03-02 | 2017-03-16 | Bevacizumab + Cape + Oxali 14day | 02 | N | 280030502 | VIDE |
| 280006219 | 280003832 | 1.61 | 6.2 | Palliative (P) | 2018-02-16 | 2018-02-19 | CISPLATIN + FLUOROURACIL + RT | 2 | N | 280030503 | PACLITAXEL |
| 280006220 | 280003833 | null | 0 | Palliative (P) | 2013-03-10 | 2013-03-31 | Mitomycin Intravesical | 02 | null | 280030504 | GEMCARBO |
| 280006221 | 280003834 | 1.63 | 70.6 | Adjuvant (A) | 2016-09-21 | 2016-09-21 | Oxaliplatin + Modified de Gramont | 02 | N | 280030508 | FEC + DOCETAXEL |
| 280006222 | 280003834 | null | 78.8 | Palliative (P) | 2016-08-19 | 2016-08-19 | BCG Intravesical | N | null | 280030508 | DOCETAXEL + GEMCITABINE |
| 280006223 | 280003834 | 1.61 | 51.5 | Curative (C) | 2017-12-26 | 2018-01-07 | Carboplatin+Fluorouracil 4 or 5 day | N | Y | 280030508 | IVADO |
| 280006224 | 280003835 | 1.72 | 82 | Palliative (P) | 2013-05-14 | 2013-05-15 | FCiSt | 2 | null | 280030511 | CETUXIMAB + CISPLATIN + FU |
| 280006225 | 280003836 | 1.8 | 67.9 | Curative (C) | 2016-08-28 | 2016-08-28 | Carboplatin + Pemetrexed | 02 | N | 280030512 | CISPLATIN + FLUOROURACIL + RT |
| 280006226 | 280003836 | 1.82 | 103.4 | Adjuvant (A) | 2014-04-30 | 2014-05-06 | Carboplatin + Pemetrexed | 02 | N | 280030512 | CARBO + FLUOROURACIL |
| 280006227 | 280003836 | 1.7 | null | Palliative (P) | 2017-09-30 | 2017-10-14 | Liposomal Doxorubicin (20mg/m2) | 02 | N | 280030512 | DOXORUBICIN + OLARATUMAB |
| 280006228 | 280003836 | 1.86 | null | null | 2014-03-27 | 2014-04-13 | Doxorubicin + Olaratumab | N | N | 280030512 | ETOPOSIDE |
| 280006229 | 280003837 | 1.64 | 84.9 | Palliative (P) | 2014-01-20 | 2014-01-20 | Trabectedin | 2 | Y | 280030517 | GEDDIS TRIAL |
| 280006230 | 280003838 | null | null | Palliative (P) | 2014-12-26 | 2015-01-12 | Doxorubicin + Olaratumab | N | N | 280030520 | CARBO + FLUOROURACIL |
| 280006231 | 280003838 | null | 79.7 | null | 2014-09-12 | 2014-09-13 | OCTREOTIDE | 2 | Y | 280030520 | FLUOROURACIL + MITOMYCIN + RT |
| 280006232 | 280003839 | 1.75 | 72 | Neo-adjuvant (N) | 2016-09-19 | 2016-09-21 | PATHOS Trial | N | N | 280030523 | EURO-EWING |
| 280006233 | 280003840 | 1.87 | 88.9 | Adjuvant (A) | 2014-09-20 | 2014-09-21 | TIMELY TRIAL | 02 | Y | 280030524 | DOCETAXEL |
| 280006234 | 280008093 | 1.71 | 82.9 | Palliative (P) | 2017-01-28 | 2017-02-09 | VIDE | N | N | 280030526 | HCX |
| 280006235 | 280008093 | null | 61.9 | Palliative (P) | 2014-06-26 | 2014-06-26 | CAPECITABINE + OXALIPLATIN | N | N | 280030526 | DOCETAXEL + GEMCITABINE |
| 280006236 | 280003841 | null | 98.75 | null | null | 2015-03-16 | Obinutuzumab | N | N | 280030528 | ETOPOSIDE |
| 280006237 | 280003841 | 1.8 | null | Curative (C) | 2017-03-16 | 2017-04-03 | Trabectedin | null | null | 280030528 | CISPLATIN + FLUOROURACIL + RT |